StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.01+0.03 (+3.30%)

Close on Nov 17, 2026Market cap $19.46MP/E –Yield –

Cocrystal Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cocrystal Pharma's pe ratio was 96.7× on Jan 31, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Jan 31, 201996.7×−23.3
2018Dec 31, 2018120.0×–

More Cocrystal Pharma figures

See a number that looks wrong?